Cargando…
Characterization and Drug Resistance Patterns of Ewing's Sarcoma Family Tumor Cell Lines
Despite intensive treatment with chemotherapy, radiotherapy and surgery, over 70% of patients with metastatic Ewing's Sarcoma Family of Tumors (EFT) will die of their disease. We hypothesize that properly characterized laboratory models reflecting the drug resistance of clinical tumors will fac...
Autores principales: | May, William A., Grigoryan, Rita S., Keshelava, Nino, Cabral, Daniel J., Christensen, Laura L., Jenabi, Jasmine, Ji, Lingyun, Triche, Timothy J., Lawlor, Elizabeth R., Reynolds, C. Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846563/ https://www.ncbi.nlm.nih.gov/pubmed/24312454 http://dx.doi.org/10.1371/journal.pone.0080060 |
Ejemplares similares
-
FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
por: Christensen, Laura, et al.
Publicado: (2013) -
CD133 expression in chemo-resistant Ewing sarcoma cells
por: Jiang, Xiaohua, et al.
Publicado: (2010) -
Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line
por: Moore, Joseph B., et al.
Publicado: (2015) -
Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth
por: Vasileva, Elena, et al.
Publicado: (2022) -
ERBB4 confers metastatic capacity in Ewing sarcoma
por: Mendoza-Naranjo, Ariadna, et al.
Publicado: (2013)